Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Long non-coding RNA H19 promotes the proliferation and invasion of lung cancer cells and regulates the expression of E-cadherin, N-cadherin, and vimentin.

Liao S, Yu C, Liu H, Zhang C, Li Y, Zhong X.

Onco Targets Ther. 2019 May 24;12:4099-4107. doi: 10.2147/OTT.S185156. eCollection 2019.

2.

Long noncoding RNA H19 is a critical oncogenic driver and contributes to epithelial-mesenchymal transition in papillary thyroid carcinoma.

Liang WQ, Zeng, Chen CF, Sun SM, Lu XF, Peng CY, Lin HY.

Cancer Manag Res. 2019 Mar 6;11:2059-2072. doi: 10.2147/CMAR.S195906. eCollection 2019.

3.

The Effect of LncRNA H19/miR-194-5p Axis on the Epithelial-Mesenchymal Transition of Colorectal Adenocarcinoma.

Li CF, Li YC, Wang Y, Sun LB.

Cell Physiol Biochem. 2018;50(1):196-213. doi: 10.1159/000493968. Epub 2018 Oct 2.

4.

Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma.

He H, Wang N, Yi X, Tang C, Wang D.

Cell Biosci. 2017 Dec 1;7:65. doi: 10.1186/s13578-017-0193-z. eCollection 2017.

5.

LncRNA H19 promotes epithelial mesenchymal transition and metastasis of esophageal cancer via STAT3/EZH2 axis.

Chen MJ, Deng J, Chen C, Hu W, Yuan YC, Xia ZK.

Int J Biochem Cell Biol. 2019 Aug;113:27-36. doi: 10.1016/j.biocel.2019.05.011. Epub 2019 May 16.

PMID:
31102664
6.

Long non-coding RNA H19 regulates viability and metastasis, and is upregulated in retinoblastoma.

Li L, Chen W, Wang Y, Tang L, Han M.

Oncol Lett. 2018 Jun;15(6):8424-8432. doi: 10.3892/ol.2018.8385. Epub 2018 Mar 29.

7.

Overexpression of long non-coding RNA H19 promotes invasion and autophagy via the PI3K/AKT/mTOR pathways in trophoblast cells.

Xu J, Xia Y, Zhang H, Guo H, Feng K, Zhang C.

Biomed Pharmacother. 2018 May;101:691-697. doi: 10.1016/j.biopha.2018.02.134. Epub 2018 Mar 22.

PMID:
29522949
8.

Targeting H19 by lentivirus-mediated RNA interference increases A549 cell migration and invasion.

Wang L, Sun Y, Yi J, Wang X, Liang J, Pan Z, Li L, Jiang G.

Exp Lung Res. 2016 Sep;42(7):346-353. Epub 2016 Sep 8.

PMID:
27607135
9.

LncRNA H19 promotes epithelial-mesenchymal transition (EMT) by targeting miR-484 in human lung cancer cells.

Zhang Q, Li X, Li X, Li X, Chen Z.

J Cell Biochem. 2018 Jun;119(6):4447-4457. doi: 10.1002/jcb.26537. Epub 2018 Mar 1.

PMID:
29219208
10.

Long noncoding RNA TPTE2P1 promotes the migration and invasion of hepatocellular carcinoma.

Liu J, Wang Z, Yin Y, Li N, Ye NY, Bao B, Gu HC.

Eur Rev Med Pharmacol Sci. 2019 May;23(9):3733-3741. doi: 10.26355/eurrev_201905_17799.

11.

LncRNA FEZF1-AS1 enhances epithelial-mesenchymal transition (EMT) through suppressing E-cadherin and regulating WNT pathway in non-small cell lung cancer (NSCLC).

He R, Zhang FH, Shen N.

Biomed Pharmacother. 2017 Nov;95:331-338. doi: 10.1016/j.biopha.2017.08.057. Epub 2017 Sep 12.

PMID:
28858731
12.

Downregulation of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma.

Ke K, Sun Z, Wang Z.

Oncol Lett. 2018 Aug;16(2):1801-1808. doi: 10.3892/ol.2018.8797. Epub 2018 May 24.

13.

Long non-coding RNA GHET1 promotes human breast cancer cell proliferation, invasion and migration via affecting epithelial mesenchymal transition.

Song R, Zhang J, Huang J, Hai T.

Cancer Biomark. 2018;22(3):565-573. doi: 10.3233/CBM-181250.

PMID:
29843220
14.

Silence of  lncRNA UCA1 rescues drug resistance of cisplatin to non-small-cell lung cancer cells.

Liu X, Huang Z, Qian W, Zhang Q, Sun J.

J Cell Biochem. 2019 Jun;120(6):9243-9249. doi: 10.1002/jcb.28200. Epub 2019 Jan 16.

PMID:
30652341
15.

LncRNA H19 regulates the expression of its target gene HOXA10 in endometrial carcinoma through competing with miR-612.

Zhang L, Wang DL, Yu P.

Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4820-4827. doi: 10.26355/eurrev_201808_15617.

16.

Effects of long non-coding RNA URHC on proliferation, apoptosis and invasion of colorectal cancer cells.

Gu ZG, Shen GH, Lang JH, Huang WX, Qian ZH, Qiu J.

Eur Rev Med Pharmacol Sci. 2018 Mar;22(6):1658-1664. doi: 10.26355/eurrev_201803_14577.

17.

Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.

Zhang Y, Jin X, Wang Z, Zhang X, Liu S, Liu G.

Cancer Biomark. 2017 Dec 12;21(1):89-96. doi: 10.3233/CBM-170286.

PMID:
29081407
18.

LncRNA H19/miR-29b-3p/PGRN Axis Promoted Epithelial-Mesenchymal Transition of Colorectal Cancer Cells by Acting on Wnt Signaling.

Ding D, Li C, Zhao T, Li D, Yang L, Zhang B.

Mol Cells. 2018 May 31;41(5):423-435. doi: 10.14348/molcells.2018.2258. Epub 2018 May 10.

19.

Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.

Zhou M, Zhang XY, Yu X.

Biomed Pharmacother. 2017 Jan;85:348-354. doi: 10.1016/j.biopha.2016.11.035. Epub 2016 Nov 28.

PMID:
27899259
20.

Supplemental Content

Support Center